peoplePerson
Sundar Jagannath
Veteran myeloma trialist who helped bring proteasome inhibitors and bispecifics to patients.
Directs Mount Sinai's myeloma centre; principal investigator across bortezomib, carfilzomib and teclistamab-era studies.
Role
Director, Center of Excellence for Multiple Myeloma
Specialisms
Multiple myelomaNovel agentsBispecific antibodies
Profiles
| Title | Journal | Year |
|---|---|---|
| Bortezomib therapy alone and in combination with dexamethasone for previously untreated symptomatic multiple myeloma | British Journal of Haematology | 2005 |
Pages like this
not linked directly; found by shared links- TrialDREAMM-7
Shares Bortezomib, Multiple myeloma.
- PersonA. Keith Stewart
Shares Carfilzomib, Multiple myeloma.
- TrialMajesTEC-3
Shares Teclistamab, Multiple myeloma.
- TrialMajesTEC-1
Shares Teclistamab, Multiple myeloma.
- PersonPaul G. Richardson
Shares Bortezomib, Multiple myeloma.
- PersonKenneth C. Anderson
Shares Bortezomib, Multiple myeloma.
- TrialCEPHEUS
Shares Bortezomib, Multiple myeloma.
- TrialIMROZ
Shares Bortezomib, Multiple myeloma.